US: Cigna And Aetna spent more than $1.3M on outside lobbying for mergers In 2015
The frenzied year of deal making that was 2015 saw, among other moves, Aetna agree in July to buy Humana for $34.1 billion, a deal which remains subject to approval by antitrust regulators. That same month, Anthem also agreed to buy Cigna for $48.4 billion, a deal that also requires regulatory approval from the Justice Department’s Antitrust Division. Where those reviews could lead and when they would be finalized remain uncertain, two questions that have sparked speculation among experts.
Featured News
Germany Targets Fuel Price Spikes With New Daily Cap on Increases
Mar 17, 2026 by
CPI
Visa and Mastercard Win Right to Appeal UK Ruling on Interchange Fees
Mar 17, 2026 by
CPI
Spain’s Antitrust and Energy Watchdog to Release Blackout Report Without Blame
Mar 17, 2026 by
CPI
White House, GOP Again Trying to Enact Federal Preemption of State AI Laws
Mar 17, 2026 by
CPI
Klobuchar Unveils Bill to Strengthen Court Oversight of Antitrust Settlements
Mar 17, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Behavioral Economics
Feb 22, 2026 by
CPI
Behavioral Antitrust in 2026
Feb 22, 2026 by
Maurice Stucke
Behavioral Economics in Competition Policy: Going Beyond Inertia and Framing Effects
Feb 22, 2026 by
Annemieke Tuinstra & Richard May
Agreeing to Disagree in Antitrust
Feb 22, 2026 by
Jorge Padilla
Recognizing What’s Around the Corner: Merger Control, Capabilities, and the New Nature of Potential Competition
Feb 22, 2026 by
Magdalena Kuyterink & David J. Teece